Stocktoria

Foghorn Therapeutics Inc. FHTX

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-10-23

Foghorn Therapeutics Inc. statistics & valuation

Market cap$247.8M
P / S8.0×
Net margin-240.3%
FCF margin-278.7%
Return on capital-62.4%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-16000.00% -7681.60% -566.30% -288.20% -383.20% -240.30% 2019202020212022202320242025
Gross margin (%)
2019202020212022202320242025
Operating margin (%)
-15937.40% -7637.10% -609.20% -315.90% -454.30% -279.50% 2019202020212022202320242025
Return on equity (%)
-47.10% -104.60% -97216.10% 2019202020212022202320242025
Shares outstanding
4.9M 36.8M 41.3M 41.8M 42.3M 55.6M 63.0M 2019202020212022202320242025
Net debt ($)
-$4.0M -$73.1M -$101.1M 2019202020212022202320242025
Share buybacks ($)
2019202020212022202320242025
Return on assets (%)
-228.80% -26.90% -19.50% -26.90% -34.40% -30.50% -37.50% 2019202020212022202320242025
Free cash flow margin (%)
-11039.30% -4060.90% 1000.60% -349.40% -448.20% -278.70% 2019202020212022202320242025
Debt / equity (×)
0.13× 0.00× 2019202020212022202320242025
EPS ($)
-$6.23 -$2.73 -$2.62 -$2.34 -$1.58 -$1.18 2019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating margin-279.5%-454.3%-315.9%-609.2%-7637.1%-15937.4%—
Net margin-240.3%-383.2%-288.2%-566.3%-7681.6%-16000.0%—
FCF margin-278.7%-448.2%-349.4%1000.6%-4060.9%-11039.3%—
Return on assets-37.5%-30.5%-34.4%-26.9%-19.5%-26.9%-228.8%
Return on equity68.5%190.3%127.5%-97216.1%-104.6%-47.1%58.1%
Debt / equity————0.00×0.13×-0.12×
Current ratio2.733.734.116.379.4410.121.33

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.